強迫性障害の世界市場レポート 2025年

強迫性障害市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.38％で9億3,000万米ドルに成長します。予測期間中、OCDの有病率の上昇、適応外薬や治療法に対する需要の増加、ヘルスケア分野への投資の増加、啓発キャンペーンの増加、政府のイニシアティブの強化などが成長を促進すると予想されます。この期間に予想される主な動向には、技術の進歩、デジタルヘルスツールの統合、治療におけるバーチャルリアリティの利用、遠隔医療サービスの拡大、認知行動療法の継続的な採用などが含まれます。

精神疾患の有病率の増加は、強迫性障害（OCD）市場の成長を促進すると予測されます。精神疾患は、気分、思考、行動、全体的な機能に影響を与える幅広い症状を包含します。OCDの増加は、認知度の向上と診断、ライフスタイルの変化、慢性的なストレス、世界の危機、社会的、経済的、環境的圧力の高まりに起因しています。OCDは精神疾患の複雑さを理解し、様々な精神疾患の調査、診断、治療法を前進させる中心的な役割を担っています。例えば、2024年9月、米国国立衛生研究所（NIH）は、2022年には米国成人の5,930万人（人口の23.1%）がAMI（Any Mental Illness）を経験し、男性（19.7%）に比べ女性（26.4%）の有病率が高いと報告しました。このような有病率の増加は、OCD関連の治療に対する需要の拡大を浮き彫りにし、市場の成長を後押ししています。

OCD市場に参入している企業は、より効果的な治療法を提供するためにメンタルヘルスの治療法を革新しています。これらの治療には、メンタルヘルス状態の管理と緩和を目的とした様々な治療法、薬物療法、生活習慣への介入が含まれます。2023年10月、ニューポートヘルスケアは10代から20代の若者向けのOCD治療プログラムを発表しました。このプログラムは、OCDやそれに関連する障害を持つ若年層の発達や心理的ニーズに対応するものです。認知行動療法（CBT）、曝露反応予防法（ERP）、家族中心のアプローチなど、エビデンスに基づいた治療法を採用することで、このプログラムは利用しやすく全人的なケアを保証します。包括的な回復を促進するために、マインドフルネスの実践、身体的健康、生活技能訓練とメンタルヘルス治療を統合しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界強迫性障害 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の強迫性障害市場：成長率分析
• 世界の強迫性障害市場の実績：規模と成長, 2019-2024
• 世界の強迫性障害市場の予測：規模と成長, 2024-2029, 2034F
• 世界強迫性障害総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の強迫性障害市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的セロトニン再取り込み阻害薬
• セロトニン・ノルエピネフリン再取り込み阻害剤
• モノアミン酸化酵素阻害剤
• セロトニン拮抗薬および再取り込み阻害剤
• 三環系強迫性障害
• 世界の強迫性障害市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大うつ病性障害
• 不安障害
• 注意欠陥多動性障害
• 世界の強迫性障害市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界の強迫性障害市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の強迫性障害市場選択的セロトニン再取り込み阻害薬（SSRI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルオキセチン
• セルトラリン
• パロキセチン
• エスシタロプラム
• 世界の強迫性障害市場セロトニン・ノルエピネフリン再取り込み阻害剤（SNRI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• デュロキセチン
• ベンラファキシン
• 世界の強迫性障害市場モノアミン酸化酵素阻害剤（MAOI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モクロベミド
• フェネルジン
• 世界の強迫性障害市場セロトニン拮抗薬および再取り込み阻害薬（SARI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• トラゾドン
• ネファゾドン
• 世界の強迫性障害市場三環性強迫性障害のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クロミプラミン
• アミトリプチリン

第7章 地域別・国別分析

• 世界の強迫性障害市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の強迫性障害市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 強迫性障害市場：競合情勢
• 強迫性障害市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Hetero Labs Limited
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Zydus Cadila
• Amneal Pharmaceuticals Inc.
• Mallinckrodt plc
• Lupin Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 強迫性障害市場2029：新たな機会を提供する国
• 強迫性障害市場2029：新たな機会を提供するセグメント
• 強迫性障害市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to alleviate anxiety. These behaviors often disrupt daily functioning and cause significant emotional distress. Common themes include concerns about cleanliness, orderliness, and fear of harm. Treatment generally involves a combination of therapy and medication.

The primary drug classes for OCD treatment include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), serotonin antagonist and reuptake inhibitors (SARIs), and tricyclic antidepressants (TCAs). SSRIs, a commonly prescribed class, function by increasing serotonin levels in the brain and preventing its reabsorption into nerve cells. These medications are also indicated for other conditions such as major depressive disorder, anxiety disorders, and attention deficit hyperactivity disorder (ADHD). The distribution channels for these drugs include hospital pharmacies, retail pharmacies, and other outlets, serving end users such as hospitals, specialty clinics, and other healthcare facilities.

The obsessive-compulsive disorder market research report is one of a series of new reports from The Business Research Company that provides obsessive-compulsive disorder market statistics, including obsessive-compulsive disorder industry global market size, regional shares, competitors with a obsessive-compulsive disorder market share, detailed obsessive-compulsive disorder market segments, market trends and opportunities, and any further data you may need to thrive in the obsessive-compulsive disorder industry. This obsessive-compulsive disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obsessive-compulsive disorder market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.64%. The growth during the historic period was driven by factors such as an increase in early diagnosis, a rising prevalence of mental health conditions, the expanded use of cognitive behavioral therapy (CBT), improved access to online therapy, and the development of personalized treatment plans.

The obsessive-compulsive disorder market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.38%. In the forecast period, growth is expected to be propelled by a rising prevalence of OCD, increasing demand for off-label drugs and therapies, heightened investment in the healthcare sector, growing awareness campaigns, and enhanced government initiatives. Key trends anticipated during this period include advancements in technology, the integration of digital health tools, the use of virtual reality in treatment, the expansion of telehealth services, and the continued adoption of cognitive behavioral therapy.

The increasing prevalence of mental illness is projected to drive growth in the obsessive-compulsive disorder (OCD) market. Mental illnesses encompass a broad spectrum of conditions that impact mood, thinking, behavior, and overall functioning. Their rise is attributed to greater awareness and diagnosis, lifestyle shifts, chronic stress, global crises, and escalating social, economic, and environmental pressures. OCD serves as a focal point for understanding the complexities of mental illnesses, advancing research, diagnosis, and treatment methods for various mental health conditions. For example, in September 2024, the National Institutes of Health (NIH) reported that in 2022, 59.3 million U.S. adults (23.1% of the population) experienced AMI (Any Mental Illness), with a higher prevalence among females (26.4%) compared to males (19.7%). This growing prevalence highlights the expanding demand for OCD-related treatments, boosting the market's growth.

Companies in the OCD market are innovating mental health treatment to deliver more effective therapeutic options. These treatments include a range of therapies, medications, and lifestyle interventions aimed at managing and alleviating mental health conditions. In October 2023, Newport Healthcare introduced a specialized OCD Treatment Program for teens and young adults. This initiative addresses the developmental and psychological needs of younger individuals with OCD and related disorders. By employing evidence-based therapies such as Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), and family-centered approaches, the program ensures accessible, holistic care. It integrates mental health treatment with mindfulness practices, physical wellness, and life skills training to promote comprehensive recovery.

In August 2023, Talkiatry partnered with NOCD to revolutionize OCD treatment through integrated services. This collaboration aims to enhance patient outcomes by combining NOCD's specialized ERP therapy with Talkiatry's psychiatric care expertise. NOCD, a U.S.-based mental health technology company, specializes in online therapy for OCD, making this partnership a strategic move to improve accessibility and streamline OCD care.

Major players in the obsessive-compulsive disorder market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Zydus Cadila, Amneal Pharmaceuticals Inc., Mallinckrodt plc, Lupin Pharmaceuticals Inc., Par Pharmaceutical, Biohaven Pharmaceuticals.

North America was the largest region in the obsessive-compulsive disorder market in 2024. The regions covered in obsessive-compulsive disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obsessive-compulsive disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obsessive-compulsive disorder market includes revenues earned by entities by providing services such as diagnosing, treating, and managing mental health conditions and related products including benzodiazepines, neurostimulation devices, and ERP therapy tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obsessive-Compulsive Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obsessive-compulsive disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obsessive-compulsive disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obsessive-compulsive disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Selective Serotonin Reuptake Inhibitors; Serotonin-Norepinephrine Reuptake Inhibitors; Monoamine Oxidase Inhibitors; Serotonin Antagonist And Reuptake Inhibitors; Tricyclic Obsessive Compulsive Disorder
• 2) By Indication: Major Depressive Disorder; Anxiety Disorders; Attention Deficit Hyperactivity Disorder
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
• 4) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine; Sertraline; Paroxetine; Escitalopram
• 2) By Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Duloxetine; Venlafaxine
• 3) By Monoamine Oxidase Inhibitors (MAOIs): Moclobemide; Phenelzine
• 4) By Serotonin Antagonist And Reuptake Inhibitors (SARI): Trazodone; Nefazodone
• 5) By Tricyclic Obsessive Compulsive Disorder: Clomipramine; Amitriptyline
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Abbott Laboratories; Novartis AG; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Obsessive-Compulsive Disorder Market Characteristics

3. Obsessive-Compulsive Disorder Market Trends And Strategies

4. Obsessive-Compulsive Disorder Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Obsessive-Compulsive Disorder Growth Analysis And Strategic Analysis Framework

• 5.1. Global Obsessive-Compulsive Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Obsessive-Compulsive Disorder Market Growth Rate Analysis
• 5.4. Global Obsessive-Compulsive Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Obsessive-Compulsive Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Obsessive-Compulsive Disorder Total Addressable Market (TAM)

6. Obsessive-Compulsive Disorder Market Segmentation

• 6.1. Global Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist And Reuptake Inhibitors
• Tricyclic Obsessive Compulsive Disorder
• 6.2. Global Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Major Depressive Disorder
• Anxiety Disorders
• Attention Deficit Hyperactivity Disorder
• 6.3. Global Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Other Distribution Channels
• 6.4. Global Obsessive-Compulsive Disorder Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.5. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Selective Serotonin Reuptake Inhibitors (SSRIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluoxetine
• Sertraline
• Paroxetine
• Escitalopram
• 6.6. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Duloxetine
• Venlafaxine
• 6.7. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Monoamine Oxidase Inhibitors (MAOIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Moclobemide
• Phenelzine
• 6.8. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Serotonin Antagonist And Reuptake Inhibitors (SARI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trazodone
• Nefazodone
• 6.9. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Tricyclic Obsessive Compulsive Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clomipramine
• Amitriptyline

7. Obsessive-Compulsive Disorder Market Regional And Country Analysis

• 7.1. Global Obsessive-Compulsive Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Obsessive-Compulsive Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Obsessive-Compulsive Disorder Market

• 8.1. Asia-Pacific Obsessive-Compulsive Disorder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Obsessive-Compulsive Disorder Market

• 9.1. China Obsessive-Compulsive Disorder Market Overview
• 9.2. China Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Obsessive-Compulsive Disorder Market

• 10.1. India Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Obsessive-Compulsive Disorder Market

• 11.1. Japan Obsessive-Compulsive Disorder Market Overview
• 11.2. Japan Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Obsessive-Compulsive Disorder Market

• 12.1. Australia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Obsessive-Compulsive Disorder Market

• 13.1. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Obsessive-Compulsive Disorder Market

• 14.1. South Korea Obsessive-Compulsive Disorder Market Overview
• 14.2. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Obsessive-Compulsive Disorder Market

• 15.1. Western Europe Obsessive-Compulsive Disorder Market Overview
• 15.2. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Obsessive-Compulsive Disorder Market

• 16.1. UK Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Obsessive-Compulsive Disorder Market

• 17.1. Germany Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Obsessive-Compulsive Disorder Market

• 18.1. France Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Obsessive-Compulsive Disorder Market

• 19.1. Italy Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Obsessive-Compulsive Disorder Market

• 20.1. Spain Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Obsessive-Compulsive Disorder Market

• 21.1. Eastern Europe Obsessive-Compulsive Disorder Market Overview
• 21.2. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Obsessive-Compulsive Disorder Market

• 22.1. Russia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Obsessive-Compulsive Disorder Market

• 23.1. North America Obsessive-Compulsive Disorder Market Overview
• 23.2. North America Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Obsessive-Compulsive Disorder Market

• 24.1. USA Obsessive-Compulsive Disorder Market Overview
• 24.2. USA Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Obsessive-Compulsive Disorder Market

• 25.1. Canada Obsessive-Compulsive Disorder Market Overview
• 25.2. Canada Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Obsessive-Compulsive Disorder Market

• 26.1. South America Obsessive-Compulsive Disorder Market Overview
• 26.2. South America Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Obsessive-Compulsive Disorder Market

• 27.1. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Obsessive-Compulsive Disorder Market

• 28.1. Middle East Obsessive-Compulsive Disorder Market Overview
• 28.2. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Obsessive-Compulsive Disorder Market

• 29.1. Africa Obsessive-Compulsive Disorder Market Overview
• 29.2. Africa Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Obsessive-Compulsive Disorder Market Competitive Landscape And Company Profiles

• 30.1. Obsessive-Compulsive Disorder Market Competitive Landscape
• 30.2. Obsessive-Compulsive Disorder Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Obsessive-Compulsive Disorder Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Otsuka Pharmaceutical Co. Ltd.
• 31.4. Astellas Pharma Inc.
• 31.5. Daiichi Sankyo Company Limited
• 31.6. Hetero Labs Limited
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Cipla Limited
• 31.9. Hikma Pharmaceuticals PLC
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Aurobindo Pharma Limited
• 31.12. Zydus Cadila
• 31.13. Amneal Pharmaceuticals Inc.
• 31.14. Mallinckrodt plc
• 31.15. Lupin Pharmaceuticals Inc.

32. Global Obsessive-Compulsive Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obsessive-Compulsive Disorder Market

34. Recent Developments In The Obsessive-Compulsive Disorder Market

35. Obsessive-Compulsive Disorder Market High Potential Countries, Segments and Strategies

• 35.1 Obsessive-Compulsive Disorder Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Obsessive-Compulsive Disorder Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Obsessive-Compulsive Disorder Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer